Scopus BioPharma (SCPS) IPO Opens 40% Higher
Tweet
Share
E-mailGet Alerts SCPS Hot Sheet
Join SI Premium – FREE
Today's IPO for Scopus BioPharma Inc. (NASDAQ: SCPS) opened for trading at $7.70 after pricing 500,000 shares of common stock at a public offering price of $5.50 per share.
The Benchmark Company, LLC acted as Sole Bookrunning Manager and Joseph Gunnar & Co., LLC acted as Co-Manager for the offering.
Scopus BioPharma Inc. is a biopharmaceutical company developing transformational therapeutics capitalizing on groundbreaking scientific and medical discoveries from leading research and academic institutions. The company's lead drug candidate is a novel, targeted immuno-oncology gene therapy for the treatment of multiple cancers. The company is also developing additional new chemical entities to treat other serious diseases with significant unmet medical needs, including systemic sclerosis.
Create E-mail Alert Related Categories
Hot IPOs, IPOs, Momentum Movers, Trader TalkRelated Entities
The Benchmark Company, IPOSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
